News &amp; Updates

New research has shown that a low-fat vegan diet rich in vegetables, fruits, whole grains, and legumes can improve insulin sensitivity in adult patients with type 1 diabetes (T1D), thus reducing their daily insulin requirements. The finding may fuel the momentum for dietary shifts in this population.

Low-fat vegan diet a game-changer for T1D?

12 Jul 2024

Osimertinib extends PFS by 3.2 years in LAURA

Osimertinib extends progression-free survival (PFS) sevenfold longer than placebo in patients with unresectable stage III EGFR-mutated non–small cell lung cancer (NSCLC) following definitive chemoradiotherapy, as shown in the primary analysis of the phase III LAURA study presented at ASCO 2024. This breakthrough makes osimertinib the first EGFR inhibitor to show benefit in a stage III setting.

Osimertinib extends PFS by 3.2 years in LAURA

Frailty ups ICU stay, mortality in older patients undergoing emergency laparotomy

Several older adults who undergo emergency laparotomy (EL) in Singapore are frail, and these patients have a longer length of stay in the intensive care unit (ICU) and a higher rate of 90-day mortality than nonfrail counterparts, a study has found.

Frailty ups ICU stay, mortality in older patients undergoing emergency laparotomy

Is fasting required prior to coronary angiography?

Patients undergoing a shorter-than-recommended fasting period prior to coronary angiography have significantly higher satisfaction scores, according to a study. This finding highlights the feasibility of revised fasting protocols.

Is fasting required prior to coronary angiography?

Real-world data support DOACs over warfarin for VTE

The direct oral anticoagulants (DOACs) apixaban and rivaroxaban trump warfarin for the treatment of venous thromboembolism (VTE) in a retrospective observational analysis comprising real-world VTE patients from Finland, Norway, and Sweden.

Real-world data support DOACs over warfarin for VTE

12 Jul 2024

DESTINY-Breast03 reports longest OS in previously treated HER2-positive mBC

Long-term follow-up of the DESTINY-Breast03 trial has reported a median overall survival (OS) of 52.6 months with trastuzumab deruxtecan (T-DXd), representing the longest reported OS in previously treated HER2-positive metastatic breast cancer (mBC) to date.

DESTINY-Breast03 reports longest OS in previously treated HER2-positive mBC

12 Jul 2024

5:2 intermittent fasting plan makes a difference in early type 2 diabetes

11 Jul 2024 by

An intermittent fasting plan consisting of 2 nonconsecutive fasting days and 5 days of habitual intake and meal replacement diet (5:2 MR) helps keep a lid on blood sugar and promote weight loss in adults with overweight or obesity and early type 2 diabetes (T2D), according to the results of the open-label EARLY* study from China.

5:2 intermittent fasting plan makes a difference in early type 2 diabetes

Body size may affect cancer prognosis

Body size appears to have an impact on the prognostic outcomes in patients with cancer, reveals a study. Both hand grip strength (HGS) and subcutaneous fat affect the influence BMI has on such prognosis.

Body size may affect cancer prognosis

$Novel antireflux device shows potential for treatment of PPI-refractory GERD$

Novel antireflux device shows potential for treatment of PPI-refractory GERD

11 Jul 2024 by

Patients suffering from gastroesophageal reflux disease (GERD) and ineffective esophageal motility (IEM) may benefit from the novel RefluxStop device implantation, a safe and minimally invasive technology that offers potential benefits, a study has shown.

Novel antireflux device shows potential for treatment of PPI-refractory GERD

11 Jul 2024

Supplements work wonders in PA-related vitamin B12 deficiency